Mateon Therapeutics Inc Share Price OTC Bulletin Board
Equities
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Sales 2022 | - | Sales 2023 | 0.07 5.84 | Capitalization | 15.27M 1.27B |
---|---|---|---|---|---|
Net income 2022 | 5M 417M | Net income 2023 | -7M -584M | EV / Sales 2022 | - |
Net Debt 2022 | 11.02M 918M | Net Debt 2023 | 12.4M 1.03B | EV / Sales 2023 | 39,53,16,686 x |
P/E ratio 2022 |
4.5
x | P/E ratio 2023 |
-1.91
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 45.17% |
Managers | Title | Age | Since |
---|---|---|---|
Vuong Trieu
CEO | Chief Executive Officer | 59 | 22/19/22 |
Director of Finance/CFO | 57 | 01/19/01 | |
Seymour H. Fein
CTO | Chief Tech/Sci/R&D Officer | 75 | 06/20/06 |
Members of the board | Title | Age | Since |
---|---|---|---|
Steven W. King
BRD | Director/Board Member | 59 | 11/20/11 |
Anthony Maida
CTO | Chief Tech/Sci/R&D Officer | 59 | 11/20/11 |
Vuong Trieu
CEO | Chief Executive Officer | 59 | 22/19/22 |
1st Jan change | Capi. | |
---|---|---|
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |